Daily Archives:
March 6th, 2013


  1. Ben Franklin Client Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration

    Particle Sciences, a leading drug delivery CRO, has teamed up with NETZSCH Premier Technologies, a leading manufacturer of wet milling and dispersing equipment, to provide drug developers with improved access to state-of-the-art pharmaceutical nanomilling equipment and full pharmaceutical development capabilities. Read more http://www.prnewswire.com/news-releases/particle-sciences-and-netzsch-premier-technologies-enter-into-collaboration-195297751.html

  2. Ben Franklin Client Saladax Receives $22.4 Million Strategic Equity Investment

    Saladax Biomedical, Inc. produces MyCare™, sophisticated blood tests that quickly, accurately, and inexpensively determine systemic chemotherapy drug levels that enable oncologists to personalize dosing for optimal results in cancer patients. The company will utilize the funds from this equity investment to support ongoing clinical development efforts that will lead to the expansion of the MyCare Continue Reading…